Theriva Biologics Stock Forecast

Sell candidate since Jun 12, 2026 Loss -16.72%

The Theriva Biologics, Inc. stock price gained 0.0395% on the last trading day (Tuesday, 23rd Jun 2026), rising from $0.253 to $0.253. During the last trading day the stock fluctuated 5.42% from a day low at $0.240 to a day high of $0.253. The price has fallen in 6 of the last 10 days and is down by -2.32% for this period. Volume fell on the last day by -475 thousand shares and in total, 591 thousand shares were bought and sold for approximately $149.50 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.214 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 7.62% during the next 3 months and, with a 90% probability hold a price between $0.230 and $0.465 at the end of this 3-month period.

TOVX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Theriva Biologics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.272 and $0.299. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, April 20, 2026, and so far it has fallen -38.29%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Theriva Biologics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.227 and $0.223. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Theriva Biologics, Inc. finds support just below today's level at $0.227. If this is broken, then the next support from accumulated volume will be at $0.223 and $0.212.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0130 between high and low, or 5.42%. For the last week the stock has had daily average volatility of 6.66%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (TOVX) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Theriva Biologics, Inc. to open at $0.249, and during the day (based on 14 day Average True Range), to move between $0.237 and $0.269, which gives a possible trading interval of +/-$0.0326 (+/-13.78%) up or down from last closing price. If Theriva Biologics, Inc. takes out the full calculated possible swing range there will be an estimated 13.78% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.227 (10.43%) than the resistance at $0.297 (17.39%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Theriva Biologics, Inc. stock A Buy?

The Theriva Biologics, Inc. stock holds several negative signals and despite the positive trend, we believe Theriva Biologics, Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -3.940 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $0.249 ( 1.71%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk